Survey of Nanomaterial Risk Management Practices, 36784-36785 [2013-14564]

Download as PDF 36784 Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices of informed consent issues in cluster randomized trials. After lunch, there will be a special expert panel discussing Certificates of Confidentiality (COCs). Following opening remarks on the morning of July 11, the Subpart A Subcommittee (SAS) will give their report. This will be followed by a discussion of the concept of engagement in human subjects research. SAS is charged with developing recommendations for consideration by SACHRP regarding the application of subpart A of 45 CFR part 46 in the current research environment; this Subcommittee was established by SACHRP in October 2006. The day will conclude with a panel discussion of issues surrounding electronic informed consent. Public attendance at the meeting is limited to space available. Individuals who plan to attend the meeting and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact persons. Members of the public will have the opportunity to provide comments on both days of the meeting. Public comment will be limited to five minutes per speaker. Any members of the public who wish to have printed materials distributed to SACHRP members for this scheduled meeting should submit materials to the Executive Director, SACHRP, prior to the close of business July 5, 2013. Dated: June 12, 2013. Jerry Menikoff, Director, Office for Human Research Protections, Executive Secretary, Secretary’s Advisory Committee on Human Research Protections. [FR Doc. 2013–14518 Filed 6–18–13; 8:45 am] BILLING CODE 4150–36–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention (CDC) [CDC–2013–0010, Docket Number NIOSH– 265] mstockstill on DSK4VPTVN1PROD with NOTICES Survey of Nanomaterial Risk Management Practices National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Proposed NIOSH Survey of Nanomaterial Risk Management AGENCY: VerDate Mar<15>2010 17:13 Jun 18, 2013 Jkt 229001 Practices; Notice of Public Meeting and Request for Comments. SUMMARY: The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) announces a public meeting and opportunity for comment on a proposed NIOSH survey. The primary purpose of the survey is to evaluate the use of NIOSH guidelines and risk mitigation practices for safe handling of engineered nanomaterials (ENMs) in the workplace. Information collected from the survey will be useful in future revisions of the guidelines. The public is invited to comment on the proposed survey through a public docket and/or participation in a one-day public meeting. To view the notice and related materials, visit http:// www.regulations.gov and enter CDC– 2013–0010 in the search field and click ‘‘Search.’’ Public comment period: Submit either electronic or written comments by September 15, 2013. Registration to attend the meeting must be received by July 17, 2013 and will be accepted on a first come first served basis. See the SUPPLEMENTARY INFORMATION section for information on how to register for the meeting. ADDRESSES: The public meeting will be held at the NIOSH Alice Hamilton building, 5555 Ridge Avenue, Cincinnati, OH 45213. The public meeting will be held on July 31, 2013, from 8 a.m. to 3:00 p.m. EDT. Security Considerations: Due to mandatory security clearance procedures at the NIOSH Alice Hamilton building, in-person attendees must present valid government-issued picture identification to security personnel upon entering the parking lot. Non-U.S. citizens: Because of CDC Security Regulations, any non-U.S. citizen wishing to attend this meeting must provide the following information in writing to the NIOSH Docket Officer at the address below no later than June 29, 2013 to allow time for mandatory CDC facility security clearance procedures to be completed. 1. Name: 2. Gender: 3. Date of Birth: 4. Place of birth (city, province, state, country): 5. Citizenship: 6. Passport Number: 7. Date of Passport Issue: 8. Date of Passport Expiration: 9. Type of Visa: 10. U.S. Naturalization Number (if a naturalized citizen): PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 11. U.S. Naturalization Date (if a naturalized citizen): 12. Visitor’s Organization: 13. Organization Address: 14. Organization Telephone Number: 15. Visitor’s Position/Title within the Organization: This information will be transmitted to the CDC Security Office for approval. Visitors will be notified as soon as approval has been obtained. You may submit comments, identified by CDC–2013–0010 and Docket Number NIOSH–265, by either of the following two methods: • Federal eRulemaking Portal: http:// www.regulations.gov. Follow the instructions for submitting comments. • Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS C–34, Cincinnati, Ohio 45226. Instructions: All information received in response to this notice must include the agency name and docket number (CDC–2013–0010; NIOSH–265). All relevant comments received will be posted without change to http:// www.regulations.gov, including any personal information provided. All electronic comments should be formatted as Microsoft Word. Please make reference to CDC–2013–0010 and Docket Number NIOSH–265. SUPPLEMENTARY INFORMATION: Attendance: The meeting is open to the public, limited only by the capacity (80) of the conference room. Confirm your attendance to this meeting by sending an email to jun1@cdc.gov by July 17, 2013. An email confirming registration will be sent from NIOSH and will include details needed to participate. Oral comments given at the meeting will be recorded and included in the NIOSH Docket Number 265. Background: NIOSH is among the world’s leaders in promoting the safe and responsible development and use of ENMs. NIOSH has published guidelines on the safe use of ENMs including ‘‘Approaches to Safe Nanotechnology: Managing the Health and Safety Concerns Associated with Engineered Nanomaterials’’ (http://www.cdc.gov/ niosh/docs/2009–125/pdfs/2009– 125.pdf) and ‘‘General Safe Practices for Working With Engineered Nanomaterials in Research Laboratories’’ (http://www.cdc.gov/ niosh/docs/2012–147/pdfs/2012– 147.pdf). Other organizations in the U.S. and around the world have also developed guidelines for the safe use of ENMs. The proposed survey will examine the extent to which these and other guidelines are implemented and the barriers to using the guidelines. E:\FR\FM\19JNN1.SGM 19JNN1 36785 Federal Register / Vol. 78, No. 118 / Wednesday, June 19, 2013 / Notices A draft questionnaire is available for review at http://www.regulations.gov. NIOSH requests public input on the content of the questionnaire and consideration of the following: (1) Apart from a survey, what alternative methods should be considered to gather this information? (2) What resources are available that can be used to identify nanomaterial producers, distributors, end-users, and R&D laboratories for inclusion in a sampling frame? (3) A web-based survey is being proposed primarily because it is costefficient and can be easy to administer. Should any other modes (telephone, mail) be considered? (4) In small and medium-sized establishments, who would be the person best suited to respond to questions addressing risk management practices for ENMs? (5) What should be the maximum amount of time needed to complete the survey? (6) Is benchmarking adherence to safe use guidelines of value to your organization? (7) What guidelines are being used by your organization to minimize worker exposure to ENMs? (8) Are there any questions in the draft survey that should be excluded? Are there any questions not included in the draft survey that should be included? FOR FURTHER INFORMATION CONTACT: Jim Boiano—jboiano@cdc.gov; 513–841– 4246 or Rebecca Tsai—rtsai@cdc.gov; 513–841–4398, NIOSH, 4676 Columbia Parkway, Mail Stop R17, Cincinnati, Ohio 45226–1998. Dated: June 13, 2013. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Administration for Children and Families Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review Submission for OMB Review; Comment Request The meeting announced below concerns Centers for Disease Control and Prevention Public Health Preparedness and Response Research to Aid Recovery from Hurricane Sandy, Request for Application (RFA) TP13– 001, initial review. Correction: The notice was published in the Federal Register on June 11, 2013, Volume 78, Number 112, Pages 35035—35036. The time, date and place should read as follows: Time and Date: 12:00 p.m.–5:00 p.m. (EST), July 10, 2013 (Closed). Place: Teleconference. Contact Person for More Information: Shoukat Qari, D.V.M., Ph.D., Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop K72, Atlanta, Georgia 30333, Telephone: (770) 488–8808. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dana Redford, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2013–14541 Filed 6–18–13; 8:45 am] BILLING CODE 4163–18–P Title: National Medical Support Notice OMB No.: 0970–0222 Description: The National Medical Support Notice (NMSN) is a two-part document that requires information from State child support enforcement agencies, employers, and health plan administrators to assist in enforcing health care coverage provisions in a child support order. The Department of Health and Human Services (DHHS), Administration for Children and Families (ACF) developed and maintains Part A of the NMSN, which is sent to an obligor’s employer for completion; the Department of Labor (DOL) developed and maintains Part B of the NMSN, which is provided to health care administrators following completion of Part A. DOL revised Part B to conform with changes to the currently approved Part A and is seeking a three year approval from OMB. To avoid burdening the State child support enforcement agencies with potential reprogramming at varying times due to future changes in either Part A or Part B, ACF is resubmitting an unchanged information collection package and requesting an extension to the current OMB approval of NMSN Part A to synchronize the expiration date with NMSN Part B. Respondents: State child support enforcement agencies, employers, and health plan administrators. [FR Doc. 2013–14564 Filed 6–18–13; 8:45 am] BILLING CODE 4163–19–P ANNUAL BURDEN ESTIMATES Number of respondents Number of responses per respondent Average burden hours per response Total burden hours National Medical Support Notice—Part A—Notice To Withhold for Health Care Coverage ............................................................................................. mstockstill on DSK4VPTVN1PROD with NOTICES Instrument 54 97,775 0.17 897,574.50 Estimated Total Annual Burden Hours: 897,574.50. Additional Information: Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Planning, Research VerDate Mar<15>2010 17:13 Jun 18, 2013 Jkt 229001 and Evaluation, 370 L’Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. Email address: infocollection@acf.hhs.gov. PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 OMB Comment: OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 78, Number 118 (Wednesday, June 19, 2013)]
[Notices]
[Pages 36784-36785]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-14564]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention (CDC)

[CDC-2013-0010, Docket Number NIOSH-265]


Survey of Nanomaterial Risk Management Practices

AGENCY: National Institute for Occupational Safety and Health (NIOSH) 
of the Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Proposed NIOSH Survey of Nanomaterial Risk Management 
Practices; Notice of Public Meeting and Request for Comments.

-----------------------------------------------------------------------

SUMMARY: The National Institute for Occupational Safety and Health 
(NIOSH) of the Centers for Disease Control and Prevention (CDC) 
announces a public meeting and opportunity for comment on a proposed 
NIOSH survey. The primary purpose of the survey is to evaluate the use 
of NIOSH guidelines and risk mitigation practices for safe handling of 
engineered nanomaterials (ENMs) in the workplace. Information collected 
from the survey will be useful in future revisions of the guidelines. 
The public is invited to comment on the proposed survey through a 
public docket and/or participation in a one-day public meeting.
    To view the notice and related materials, visit http://www.regulations.gov and enter CDC-2013-0010 in the search field and 
click ``Search.''
    Public comment period: Submit either electronic or written comments 
by September 15, 2013.
    Registration to attend the meeting must be received by July 17, 
2013 and will be accepted on a first come first served basis. See the 
SUPPLEMENTARY INFORMATION section for information on how to register 
for the meeting.

ADDRESSES: The public meeting will be held at the NIOSH Alice Hamilton 
building, 5555 Ridge Avenue, Cincinnati, OH 45213. The public meeting 
will be held on July 31, 2013, from 8 a.m. to 3:00 p.m. EDT.
    Security Considerations: Due to mandatory security clearance 
procedures at the NIOSH Alice Hamilton building, in-person attendees 
must present valid government-issued picture identification to security 
personnel upon entering the parking lot.
    Non-U.S. citizens: Because of CDC Security Regulations, any non-
U.S. citizen wishing to attend this meeting must provide the following 
information in writing to the NIOSH Docket Officer at the address below 
no later than June 29, 2013 to allow time for mandatory CDC facility 
security clearance procedures to be completed.

 1. Name:
 2. Gender:
 3. Date of Birth:
 4. Place of birth (city, province, state, country):
 5. Citizenship:
 6. Passport Number:
 7. Date of Passport Issue:
 8. Date of Passport Expiration:
 9. Type of Visa:
10. U.S. Naturalization Number (if a naturalized citizen):
11. U.S. Naturalization Date (if a naturalized citizen):
12. Visitor's Organization:
13. Organization Address:
14. Organization Telephone Number:
15. Visitor's Position/Title within the Organization:

    This information will be transmitted to the CDC Security Office for 
approval. Visitors will be notified as soon as approval has been 
obtained.
    You may submit comments, identified by CDC-2013-0010 and Docket 
Number NIOSH-265, by either of the following two methods:
     Federal eRulemaking Portal: http://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: NIOSH Docket Office, Robert A. Taft Laboratories, 
4676 Columbia Parkway, MS C-34, Cincinnati, Ohio 45226.
    Instructions: All information received in response to this notice 
must include the agency name and docket number (CDC-2013-0010; NIOSH-
265). All relevant comments received will be posted without change to 
http://www.regulations.gov, including any personal information 
provided. All electronic comments should be formatted as Microsoft 
Word. Please make reference to CDC-2013-0010 and Docket Number NIOSH-
265.

SUPPLEMENTARY INFORMATION: Attendance: The meeting is open to the 
public, limited only by the capacity (80) of the conference room. 
Confirm your attendance to this meeting by sending an email to 
jun1@cdc.gov by July 17, 2013. An email confirming registration will be 
sent from NIOSH and will include details needed to participate. Oral 
comments given at the meeting will be recorded and included in the 
NIOSH Docket Number 265.
    Background: NIOSH is among the world's leaders in promoting the 
safe and responsible development and use of ENMs. NIOSH has published 
guidelines on the safe use of ENMs including ``Approaches to Safe 
Nanotechnology: Managing the Health and Safety Concerns Associated with 
Engineered Nanomaterials'' (http://www.cdc.gov/niosh/docs/2009-125/pdfs/2009-125.pdf) and ``General Safe Practices for Working With 
Engineered Nanomaterials in Research Laboratories'' (http://www.cdc.gov/niosh/docs/2012-147/pdfs/2012-147.pdf). Other organizations 
in the U.S. and around the world have also developed guidelines for the 
safe use of ENMs. The proposed survey will examine the extent to which 
these and other guidelines are implemented and the barriers to using 
the guidelines.

[[Page 36785]]

    A draft questionnaire is available for review at http://www.regulations.gov.
 NIOSH requests public input on the content of the questionnaire and 
consideration of the following:
    (1) Apart from a survey, what alternative methods should be 
considered to gather this information?
    (2) What resources are available that can be used to identify 
nanomaterial producers, distributors, end-users, and R&D laboratories 
for inclusion in a sampling frame?
    (3) A web-based survey is being proposed primarily because it is 
cost-efficient and can be easy to administer. Should any other modes 
(telephone, mail) be considered?
    (4) In small and medium-sized establishments, who would be the 
person best suited to respond to questions addressing risk management 
practices for ENMs?
    (5) What should be the maximum amount of time needed to complete 
the survey?
    (6) Is benchmarking adherence to safe use guidelines of value to 
your organization?
    (7) What guidelines are being used by your organization to minimize 
worker exposure to ENMs?
    (8) Are there any questions in the draft survey that should be 
excluded? Are there any questions not included in the draft survey that 
should be included?

FOR FURTHER INFORMATION CONTACT: Jim Boiano_jboiano@cdc.gov; 513-841-
4246 or Rebecca Tsai_rtsai@cdc.gov; 513-841-4398, NIOSH, 4676 Columbia 
Parkway, Mail Stop R17, Cincinnati, Ohio 45226-1998.

    Dated: June 13, 2013.
John Howard,
Director, National Institute for Occupational Safety and Health, 
Centers for Disease Control and Prevention.
[FR Doc. 2013-14564 Filed 6-18-13; 8:45 am]
BILLING CODE 4163-19-P